Genetic alterations such as those in TP53, HER2, and KRAS associated with non–small cell lung cancer were found to overlap with those in squamous metaplasia or atypical alveolar hyperplasia, indicating that such metaplasia and hyperplasia are preneoplastic lesions15–17. This evidence concerns the gene KRAS and lung cancer.